GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » Cyclically Adjusted PB Ratio

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Cyclically Adjusted PB Ratio : 2.34 (As of May. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio?

As of today (2024-05-24), PT Kalbe Farma Tbk's current share price is $17.03. PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $7.28. PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio for today is 2.34.

The historical rank and industry rank for PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio or its related term are showing as below:

PTKFY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.8   Med: 5.63   Max: 7.34
Current: 4.23

During the past years, PT Kalbe Farma Tbk's highest Cyclically Adjusted PB Ratio was 7.34. The lowest was 3.80. And the median was 5.63.

PTKFY's Cyclically Adjusted PB Ratio is ranked worse than
78.17% of 687 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs PTKFY: 4.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted book value per share data for the three months ended in Mar. 2024 was $6.277. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7.28 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Historical Data

The historical data trend for PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.64 5.45 5.55 6.35 4.47

PT Kalbe Farma Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.23 5.96 5.00 4.47 4.00

Competitive Comparison of PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio falls into.



PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=17.03/7.28
=2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, PT Kalbe Farma Tbk's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.277/130.6070*130.6070
=6.277

Current CPI (Mar. 2024) = 130.6070.

PT Kalbe Farma Tbk Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.960 93.015 4.156
201409 3.075 94.576 4.246
201412 3.200 98.819 4.229
201503 3.237 98.388 4.297
201506 3.063 99.766 4.010
201509 2.920 101.037 3.775
201512 3.237 102.133 4.139
201603 3.542 102.764 4.502
201606 3.475 103.212 4.397
201609 3.709 104.142 4.652
201612 3.782 105.222 4.694
201703 4.003 106.476 4.910
201706 3.875 107.722 4.698
201709 4.005 108.020 4.842
201712 4.183 109.017 5.011
201803 4.303 110.097 5.105
201806 3.951 111.085 4.645
201809 3.982 111.135 4.680
201812 4.309 112.430 5.006
201903 4.559 112.829 5.277
201906 4.425 114.730 5.037
201909 4.612 114.905 5.242
201912 4.878 115.486 5.517
202003 4.285 116.252 4.814
202006 4.875 116.630 5.459
202009 4.878 116.397 5.474
202012 5.265 117.318 5.861
202103 5.363 117.840 5.944
202106 5.266 118.184 5.820
202109 5.538 118.262 6.116
202112 5.855 119.516 6.398
202203 6.033 120.948 6.515
202206 5.517 123.322 5.843
202209 5.522 125.298 5.756
202212 5.603 126.098 5.803
202303 6.086 126.953 6.261
202306 5.787 127.663 5.920
202309 5.758 128.151 5.868
202312 6.007 129.395 6.063
202403 6.277 130.607 6.277

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PT Kalbe Farma Tbk  (OTCPK:PTKFY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines